|
AAPS 2009 has drawn to a close but over the three days numerous trends and debates emerged, including the strategies CROs are using in the downturn, and we take a look at these in our conference round up. Published: 12-Nov-2009 |
|
Following the first full day of AAPS 2009 in Los Angeles, California, US we take a look at the major developments and talking points. Published: 10-Nov-2009 |
| Gerben Moolhuizen, OctoPlus and Hans Baumeister, GlycotopeJames Easson, Merk KGaA - Shirley Dann, SCM PharmaHow successful was the BioPh conference in Madrid? in-PharmaTechnologist asked key players attending the inaugural event. Published: 29-Oct-2009 |
|
Henry Hussell, marketing manager at Cargill Pharma, talks about Zerose erythritol's development since it was launched at CPhI 2008. Published: 19-Oct-2009 |
|
As CPhI 2009 draws to a close we take a look back on the show, which, despite some negatives, appears to have been an overall success. Published: 15-Oct-2009 |
| David BackerBusiness development and marketing director - SAFC PharmaSAFC Pharma has added extra viral and biologics capacity at its California plant in a $12m project that allows it to take projects from the lab to commercial scale. Published: 14-Oct-2009 |
|
We look ahead to CPhI 2009 which takes place in Madrid, Spain next week and will showcase the world’s leading ingredients, contract services, machinery and biotech companies. Published: 08-Oct-2009 |
| Jeffrey Hirsch, product manager NIR Analyzers, Thermo Fisher ScientificFrederik Jaenen, Sipat team manager, SiemensUS group Thermo Fisher Scientific and industrial engineering giant Siemens have teamed up to offer the pharmaceutical industry a new way of assessing processes used during early drug development, manufacturing scale up and commercial production. Published: 01-Jul-2009 |
| Eric Carlson, vice president, life science technologyMatthew Pino, director, business operations - SymyxAt BIO 2009 Symyx was promoting its new CDMO offering, which it believes meets a “real need in the industry” and can save clients time and materials by leveraging its prior knowledge. Published: 03-Jun-2009 |
| Nick TaylorScience Reporter - in-PharmaTechnologistin-Pharmatechnologist's Nick Taylor looks back on BIO 2009, an event at which uncertainty about the development of the biotechnology industry’s future shape dominated proceedings. Published: 22-May-2009 |
| Pierre VimontAmbassador to the US - FranceHEM Pierre Vimont, Ambassador of France to the US, was at BIO 2009 talking about the measures his nation have taken to attract biotechs, including the introduction of the "most favourable R&D tax in Europe". Published: 20-May-2009 |
| Dermot PearsonProduct Director - Novozymes BiopharmaTwo recombinant human albumins made by Novozymes' biopharma division have become the first to comply with the USP-NF's recently revised excipient monograph. Published: 04-May-2009 |
| Tom BeilVP of Quality and Regulatory affairs - SAFCTom Beil, SAFC’s VP of Quality and Regulatory affairs, whose talk on fine chemicals supply was a highlight of last month's DCAT week, spoke with in-PharmaTechnologist about the benefits and risks of working with global suppliers. Published: 07-Apr-2009 |
| Michael SchmittPresident, Food Americas and Global Pharmaceuticals - Alcan PackagingMichael Schmitt, president of Alcan Global Pharmaceutical Packaging, believes a recovery in the global economy, the increasing demand for quality and the emergence of markets like India and Brazil will be key drivers for the packaging sector over the next few years. Published: 23-Mar-2009 |
|
This week in-PharmaTechnologist's Pharma Phacts podcast focuses on a nanotechnology method that could produce more effective barrier packaging using less material. Published: 25-Feb-2009 |
|
New research suggests that deuteration, the replacement of hydrogen atoms with heavier forms, can alter an API's crystallisation properties and help drugmakers make better more effective drugs. Published: 09-Feb-2009 |
| Matt StoberSpokesman - NovartisLate last week the US Department of Health and Human Services (HHS) awarded Novartis a $490m contract to continue work on its cell-culture influenza vaccine plant in Holly Springs, North Carolina, US. in-PharmaTechnologist spoke with Novartis spokesman Matt Stober about the new plant. Published: 21-Jan-2009 |
| Aurore DomangePharmapack Managerin-PharmaTechnologist is joined by Aurore Domange, Pharmapack Manager, who details the highlights of this year’s show, which starts in Paris, France, this week. Published: 19-Jan-2009 |
| Nevin ChengIPEC China president - ColorconSince its inauguration last year, IPEC China has been working to improve the quality of excipient manufacturing in the country. in-PharmaTechnologist spoke with organisation president Nevin Cheng about the steps the body has taken so far and what it will be doing in 2009, including its plans for a new SFDA approved Drug Master File (DMF) scheme. Published: 12-Jan-2009 |
| Heidi Ullbergresearch scientist - McCrone AssociatesThe timely identification of contaminants in pharmaceutical manufacture can be critical to avoiding costly delays. While it is relatively straightforward to establish the composition of a contaminating particle, determining its origin in the manufacturing process can be much more problematic. in-PharmaTechnologist spoke with McCrone Associates' Heidi Ullberg at this year's AAPS in Atlanta about a light microscopy that can help drugmakers address this problem. Published: 11-Dec-2008 |
| John SantiniCEO - MicroCHIPSAfter collecting the drug delivery award at this year's AAPS, John Santini, CEO of MicroCHIPS, was on hand to explain what the gong meant to the company. Published: 25-Nov-2008 |
| Dr Karen Habuckypresident - AAPSAmerican Association of Pharmaceutical Scientist's (AAPS) president Dr Karen Habucky sets out the programme for the group's forthcoming annual meeting and exposition, which is being held in Atlanta, US between November 16- 20. Published: 10-Nov-2008 |
|
All the breaking news across the pharmaceutical manufacturing and outsourcing sectors. Published: 03-Nov-2008 |
|
Welcome to in-pharma technologist’s podcast. In the next three minutes Gareth Macdonald will take you through the top industry headlines this week. Product authenticity dominated the news, with US regulators announcing increased penalties for those convicted of selling dangerous counterfeits. In Europe IPEC sets out its new third party assessment scheme. Published: 21-Oct-2008 |